
按类型(材料挤出,粘合剂喷射,粉末床融合和增值税光聚合剂化),按应用(大众生产和个性化医学)和区域预测到2031年
地区: 全球的 | 格式: PDF | 报告编号: PMI2264 | SKU 编号: 26440796 | 页数: 117 | 发布日期 : April, 2024 | 基准年份: 2023 | 历史数据: 2019 - 2022
详细的全球3D印刷在药品市场研究报告中的TOC 2024(状态和前景)
目录的表
1研究方法和统计范围
1.1药品中的3D打印的市场定义和统计范围
1.2关键市场片段
1.2.1 1.2.1在药物段中按类型
1.2.2 1.2.2 1.2.2在应用程序
3D印刷段中,由应用程序
1.3方法论
1.3方法论
Invorys&Information
1.3.1.3.1.3 Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 3D Printing in Pharmaceutical Market Overview
2.1 Global Market Overview
2.1.1 Global 3D Printing in Pharmaceutical Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global 3D Printing in药物销售估算和预测(2019-2030)
2.2市场部门的执行摘要
2.3全球市场规模按地区按地区划分的全球市场规模
3 3D印刷在制药市场竞争性景观中
3.1 3.1制造商制造商(2019-2024)的制造商(2019-2024)
全球3D印刷品的制造商制造商制造商销售中的全球3D印刷(2019-2024)
3.3 3D印刷公司类型(第1层,第2层和第3层和第3层)
3.4制造商在药品平均价格(2019-2024)
3.5 3.5 3.5制造商3D制造商3D印刷的销售现场,竞争现场,产品类型
3.6 3.4趋势
3.6.1制药市场浓度率的3D打印
3.6.2全球5和10最大的3D印刷在药物球员市场份额中按收入划分的市场份额
3.6.3 3.6.3合并和收购,扩展,扩展
4 3D制药行业链分析中的4.1 4.1 3D打印
4.1 3D打印
4.1 3D打印
4.1 3D印刷
4.1 4.1 3D打印
4.1 Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of 3D Printing in Pharmaceutical Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3扩展
5.5.4协作/供应合同
5.6行业政策
6 3D在药品市场细分中按类型按类型进行细分
6.1 6.1评估市场发展潜力的评估矩阵(类型)
6.2 6.2全球3D在类型上按类型(2019-2024)
6.3 Global inty in type in Type in Type in type in type in type in type in type in type ybr>
6.3全局
6.3全局
全局
(2019-2024)
6.4 6.4按类型(2019-2024)按药品价格打印的全局3D打印
7 3D在药品市场细分中按应用程序进行分割
7.1第7.1个段市场开发潜力的评估矩阵(应用)
7.2 7.2全球3D印刷在Application(Application sigaltial sigeption in Application in Application in Application in Application in Application(2019-20-20-20-20-20)
3.3 USD) by Application (2019-2024)
7.4 Global 3D Printing in Pharmaceutical Sales Growth Rate by Application (2019-2024)
8 3D Printing in Pharmaceutical Market Segmentation by Region
8.1 Global 3D Printing in Pharmaceutical Sales by Region
8.1.1 Global 3D Printing in Pharmaceutical Sales by Region
8.1.2 Global 3D Printing in Pharmaceutical Sales Market Share by Region
8.2 North America
8.2.1 North America 3D Printing in Pharmaceutical Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe 3D Printing in Pharmaceutical Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6俄罗斯
8.4亚太地区
8.4.1亚太地区3D在药品销售中按地区按地区进行的
8.4.2中国
8.4.3日本
日本
8.4.4韩国
8.4.5印度
8.4.5印度
8.4.6东南亚
South Asia
South America
South America
South America
South America 3d braz braz braz braz braz braz braz braz braz braz braz braz braz braz braz braz y 8.5.2.2.2阿根廷
8.5.4哥伦比亚
8.6中东和非洲
8.6.1中东和非洲3D印刷在药品销售中按地区按地区进行
8.6.2 Saudi Arabia
8.6.3.6.3 UAE
8.6.6.6.4埃及8.6.5 Nigeria
8.6.5 Nigeria
Nigeria
Nigeria
8.6.6.6.6.6.6.6.6.6 key
9.9.10 key
earper
ichbr>
9凯 Pharmaceuticals
9.1.1 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Basic Information
9.1.2 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Product Overview
9.1.3 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Product Market Performance
9.1.4 Aprecia Pharmaceuticals Business Overview
9.1.5 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical SWOT Analysis
9.1.6 Aprecia Pharmaceuticals Recent Developments
9.2 Triastek
9.2.1 Triastek 3D Printing in Pharmaceutical Basic Information
9.2.2 Triastek 3D Printing in Pharmaceutical Product Overview
9.2.3 Triastek 3D Printing in Pharmaceutical Product Market性能
9.2.4 Triastek业务概述
9.2.5 Triastek 3D印刷在药品SWOT分析中
9.2.6 Triastek最近的进展
9.3 9.3 FabRX
9.3.1 FabRX 3D制药基本信息中的Fabrx 3D打印在制药基本信息中制药产品市场性能
9.3.4 FabRX 3D打印在制药SWOT分析中概述
9.4.3乘法实验室3D打印在药品产品市场性能中
9.4.4乘法实验室业务概述
9.4.5 9.4.5乘法实验室最新的发展
9.5 Craft Health
Craft Health
9.5.1 Craft Health 3D Practical Information in Pharmace -actacutical Informa in Pharmaceutical Product Market Performance
9.5.4 Craft Health Business Overview
9.5.5 Craft Health Recent Developments
9.6 DiHeSys
9.6.1 DiHeSys 3D Printing in Pharmaceutical Basic Information
9.6.2 DiHeSys 3D Printing in Pharmaceutical Product Overview
9.6.3 DiHeSys 3D Printing in Pharmaceutical Product Market Performance
9.6.4 DiHeSys Business Overview
9.6.5 DiHeSys Recent Developments
9.7 Merck
9.7.1 Merck 3D Printing in Pharmaceutical Basic Information
9.7.2 Merck 3D Printing in Pharmaceutical Product Overview
9.7.3 Merck 3D Printing in Pharmaceutical Product Market Performance
9.7.4 Merck Business概述
9.7.5 Merck最近的发展
9.8 Astrazeneca
9.8.1 Astrazeneca 3D在药品基本信息中印刷
9.8.2 Astrazeneca 3D在制药产品概述中的Astrazeneca 3D打印
9.8.3 Astrazeneca 3D Princeen in Pharmace in Parteraze in Pharmace in Parteragen In Parteraken In in PharmAce in Partherake Markettical in Pharmace Markettical in Comparting in Parmerace in Comparting Bright
9.9.8概述
9.8.5 Astrazeneca最近的发展
10 3D在药品市场预测中按地区预测
10.1 10.1全球3D印刷在制药市场规模预测中的全球3D打印
10.2 10.2全球3D印刷在该地区按国家 /地区按国家尺寸划分为
10.2.2 excore
10.2.2欧洲的制药市场预测的全球3D印刷
2.2国家 /地区
10.2.3亚太地区在药品市场规模预测中按地区预测
10.2.4南美3D印刷在药品市场规模预测中按国家预测
10.2.5中东和非洲预测中东和非洲预测在国家 /地区按应用程序和应用程序进行制药的3D打印的3D打印
预测
按应用程序和应用程序(20225-2030)
)预测按类型(2025-2030)
11.1.1 11.1.1按类型(2025-2030)在药品中的3D打印的全球预测销售(2025-2030)
11.1.2 11.1.2全球3D全球3D在制药市场规模上按类型(2025-2030)预测(2025-2030) (2025-2030)
11.2在药品市场预测中按应用(2025-2030)进行全球3D打印
11.2.1 11.2.1全球3D印刷在药品销售(K单位)预测中按应用程序预测
11.2.2.2 11.2.2 11.2.2全球3D全球3D印刷在应用程序市场尺寸(M USD)尺寸(M usd)preecast and keep(M usd)<20230 <202330 <